Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo.

AUTOR(ES)

Theodos, C M

RESUMO

Recombinant human tumor necrosis factor (TNF) and purified murine TNF were both able to activate macrophages to destroy intracellular Leishmania major in vitro. In addition, parasitizing macrophages with L. major markedly increased the ability of the cells to produce TNF. Finally, when mice were vaccinated with an avirulent form of L. major, the animals produced large amounts of TNF but no gamma interferon in response to infection with virulent L. major. Treating these mice with a neutralizing anti-TNF antibody led to partial but not complete inhibition of the resistant state, which suggests that factors other than TNF and gamma interferon contribute to resistance to L. major.

Documentos Relacionados

• Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
• Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.
• Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.
• Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.
• Colchicine prevents tumor necrosis factor-induced toxicity in vivo.